Scott E. Smith - Concepedia

Author

Scott E. Smith

Also Known As

Anthony Jaslowski, Ian Williams, Lewis, Lionel D., S E Smith, S Smith, S. E. Smith, S. Smith, S.E. Smith, Scott E Smith, Scott E. Smith

200

Publications

8.5K

Citations

H-Index

Concepts

All Affiliations

Loyola University Medical Center The University of Texas MD Anderson Cancer Center The Ohio State University Loyola University Chicago Washington University in St. Louis

About

Scott E. Smith is an author at Loyola University Medical Center specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	2.2K
2	Health Sciences	4	4	294
3	Public Health	3	3	49
4	Social Sciences	3	3	892
5	Anatomy	1	1	10

Scott E. Smith

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma Anas Younes, Ajay K. Gopal, Scott E. Smith, Journal of Clinical Oncology	2012	1.5K
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema, New England Journal of Medicine	2018	927
Tryptophan depletion causes a rapid lowering of mood in normal males Simon N. Young, Scott E. Smith, Robert O. Pihl, Psychopharmacology PsychopathologyStress HormoneMedicineTryptophan DepletionPsychopharmacology	1985	720
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis Adam M. Petrich, Mitul Gandhi, Borko Jovanovic, Blood	2014	461
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma Robert Chen, Ajay K. Gopal, Scott E. Smith, Blood	2016	389
Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era Andrew M. Evens, Kevin A. David, Irene Helenowski, Journal of Clinical Oncology Solid Organ TransplantationImmunologySurgeryImmunotherapyPtld Diagnosis	2010	314
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma Ajay K. Gopal, Robert Chen, Scott E. Smith, Blood	2014	221
Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium Sonali M. Smith, Koen van Besien, Theodore Karrison, Journal of Clinical Oncology	2010	207
High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia Susan O’Brien, Gary J. Schiller, John Lister, Journal of Clinical Oncology	2012	185
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies Nancy L. Bartlett, Robert Chen, Michelle A. Fanale, Journal of Hematology & Oncology	2014	178

Page 1